Showing results (91-100 of 122) with videos related to
Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphomaR Somers, P Carde, J Thomas, et al.Acta Clinica Belgica|January 1, 1992
Large granular lymphocyte proliferative disease: 21 Belgian cases and review of the literatureP G Pierre, A Bosly, R De Bock, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Phase I study of MEN-10755, a new anthracycline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies GroupD Schrijvers, A M E Bos, J Dyck, et al.Psychological Medicine|October 7, 2008
Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversityM Wichers, D Schrijvers, N Geschwind, et al.Seminars in Oncology|June 1, 1987
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemiaP Stryckmans, T De Witte, N Bitar, et al.Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.Leukemia|May 1, 1988
Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemiaZ N Berneman, D R van Bockstaele, M Van den Bergh, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2000
Factors determining the place of palliative care and death of cancer patientsB Van den Eynden, I Hermann, D Schrijvers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancerA Heidenreich, S K Rawal, K Szkarlat, et al.Journal of Thrombosis and Haemostasis : JTH|September 9, 2015
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disordersM Jacquemin, J Toelen, J Schoeters, et al.Pageof 13